<DOC>
	<DOCNO>NCT01793506</DOCNO>
	<brief_summary>The purpose study evaluate novel screen test detect patient primary immunodeficiency ( PIDs ) . The investigator plan use information gain study order advance field clinical immunology , thus improve diagnosis , treatment , well-being future patient . The purpose study determine screen test able detect patient immune problem , investigator test patient know PIDs determine test accurate The investigator hypothesize detect serum immunoglobulin dry blood spot effective detect patient know primary immunodeficiency . If hypothesis confirm , open possibility use point care test screen primary immune deficiency . Age study subject range 1 year 80 year age , recruit form Immunodeficiency clinic Medical College Wisconsin/Children 's Hospital Wisconsin ( MCW/CHW ) . Any subject test do evaluate immune system eligible study . This include patient know PIDs well patient evaluate suspected immunodeficiency . It anticipate 150 subject analyze two year period .</brief_summary>
	<brief_title>Novel Testing Procedures</brief_title>
	<detailed_description>After consent obtain , blood obtain . The total amount blood drawn one day exceed 1.5 mL ( 1/3 tsp ) per pound body weight . All sample collect time routine blood draw order physician . Subject sample de-identified Principal Investigator ( PI ) give serial number . The PI retain secure log serial number basic identifier ( name , Date Birth ( DOB0 , sex , preliminary diagnosis , test result ) , subject sample store secured freezer . Only PI access secure log book . All study test result keep compact disc , similar computer storage device , secure area accessible PI . Study test result keep computer accessible individual . The sample sell third party . The result research conveyed third party . If subject withdraw withdrawn study identifiable biological sample subject discard . The sample available type test outside study .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<criteria>Any subject test do evaluate immune system eligible study . Inability unwillingness part parent individual provide clinical family history , refusal allow blood sampling .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>immunodeficiency</keyword>
</DOC>